Login to Your Account

Adimab Signs Two New Antibody Deals

By Catherine Shaffer
Staff Writer

Tuesday, August 20, 2013
Adimab LLC, of Lebanon, N.H., announced two new collaborations centered on its platform for generating therapeutic antibodies. In a deal with Celgne Corp., of Summit, N.J., Adimab will use its technology to identify fully human antibodies against multiple targets, and for each, will give Celgene the right to develop and commercialize resulting antibodies.

To continue reading subscribe now to Latest News

Learn More about Latest News

Already a subscriber? Sign In or Buy now to activate your subscription